Human coronaroviruses;Coronavirus humains

Virologie

Volumn 9, Issue 4, 2005, Pages 273-287

  Vabret, A ^a   Mourez, T ^a   Dina, J ^a   Freymuth, F ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Coronavirus; Molecular assays; Respiratory tract illness; Severe acute respiratory syndrome (SARS)

Indexed keywords

ANTIVIRUS AGENT; RNA; VACCINE;

BIRD; CORONAVIRUS; GENE DELETION; GENE MUTATION; GENETIC RECOMBINATION; GENOME; HUMAN; MAMMAL; POLYMERASE CHAIN REACTION; REVIEW; SARS CORONAVIRUS; VIRUS INFECTION;

AVES; CORONAVIRUS; HUMAN CORONAVIRUS; MAMMALIA; SARS CORONAVIRUS; SARS COV;

EID: 24644514306     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Almeida JD, Berry DM, Cunnig CH, et al. Coronaviruses. Nature 1968; 200: 650.
2. Almeida JD, Tyrell DAJ. The morphology of three previously uncharacterized human respiratory viruses in that grow in organ culture. J Gen Virol 1967; 1: 175-8.
3. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966; 121: 190-3.
4. Mcintosh K, Dees J, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci USA 1967; 57: 933-40.
5. Revision of the taxonomy of the Coronavirus, Torovirus and Arterivirus genera. Arch Virol 1994; 135: 227-37.
6. Cavanagh D. Nidovirales: a new order comprising Coronaviridae and Arterivirida. Arch Virol 1997; 142(3): 629-33.
7. Cowley JA, Dimmock CM, Spann KM, Walker PJ. Gill-associated virus of Penaeus monodon prawns: an invertebrate virus with ORF1a and ORF1b genes related to arteri- and coronaviruses. J Gen Virol 2000; 81: 1473-84.
8. Gonzalez JM, Gomez-Puertas P, Cavanagh D, Gorbalenya AE, Enjuanes L. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol 2003; 148: 2207-35.
9. Ksiazek TG, Erdman D, Goldsmith C, et al., SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1947-58.
10. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967-76.
11. Fouchier RA, Kuiken T, Schutten M, et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003; 423: 240.
12. Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003; 362: 263-70.
13. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003; 300: 1394-9.
14. Eickmann M, Becker S, Klenk HD, et al. Phylogeny of the SARS Coronavirus. Science 2003; 302: 1504-5.
15. Stanhope MJ, Brown JR, Amrine-Madsen H. Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV. Infect Genet Evol 2004; 4: 15-9.
16. Stavrinides J, Guttman DS. Mosaic evolution of the severe acute respiratory syndrome coronavirus. J Virol 2004; 78: 76-82.
17. Van Der Hoek L, Pyre K, et al. Identification of a new human coronavirus. Nature Med 2004; 10: 368-73.
18. Fouchier RAM, Hartwig NG, Bestebroer TM, et al. A previously undescribed Coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 2004; 101: 6212-6.
19. Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005; 79: 884-95.
20. Vijgen L, Keyaerts E, Moes E, et al. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol 2005; 79: 1595-604.
21. Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 2005; 191: 492-8.
22. Lai M, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res 1997; 48: 1-100.
23. Xu Z, Zhang H, Tian X, et al. The R protein of SARS-CoV: analyses of structure and function based on four complete genome sequences of isolates BJ01-BJ04. Genomics Proteomics Bioinformatics 2003; 1: 155-65.
24. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS Coronavirus from animals in Southern China. Science 2003; 302: 276-8.
25. Rowe CL, Baker SC, Nathan MJ, Sgro JY, Palmenberg AC, Fleming JO. Quasispecies development by high frequency RNA recombination during MHV persistence. In: Enjuanes, et al., eds. Coronaviruses and Arteriviruses. New York: Plenum Press, 1998: 759-65.
26. Dongping XU, Zhang Z, Wang FS. SARS-associated Coronavirus quasispecies in individual patients. N Engl J Med 2004; 13: 1366-7; (350).
27. Rasschaert D, Duarte M, Laude H. Porcine respiratory coronavirus differs from transmissible gastroenteritis virus by a few genomic deletions. J Gen Virol 1990; 71: 2599-607.
28. Laude H, Rasschaert D, Delmas B, Eleouët JF. Le coronavirus respiratoire porcin PRCV: un virus émergent pas comme les autres. Virologie 1998; 2: 305-16.
29. Holmes KV, Behnke JN. Evolution of a coronavirus during persistent infection in vitro. Adv Exp Med Biol 1981; 142: 287-99.
30. Arbour N, Cote G, Lachance C, Tardieu M, Cashman NR, Talbot PJ. Acute and persistent infection of neural cell lines by human coronavirus OC43. J Virol 1999; 73: 3338-50.
31. Arbour N, Day R, Newcombe JIA, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol 2000; 74: 8913-21.
32. Horzinek MC. Molecular evolution of Corona- and Torovirus. In: Paul, Francis, eds. Mechanisms in the pathogenesis of enteric diseases 2. New York: Kluwer Academic/Plenum Publishers, 1999: 61-72.
33. Sturman LS, Holmes KV, Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J Virol 1980; 33: 449-62.
34. Risco C, Anton IM, Enjuanes L, Carrascosa JL. The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins. J Virol 1996; 70: 4773-7.
35. Rottier PJM. The coronavirus membrane glycoprotein. In: Siddell SG, ed. The Coronaviridae. New York: Plenum Press, 1995.
36. Laude H, Masters PS. The Coronavirus Nucleocapsid Protein. In: Siddell SG, ed. The Coronaviridae. New York: Plenum Press, 1995.
37. Cavanagh D. The coronavirus surface glycoprotein. In: Siddell SG, ed. The Coronaviridae. New York: Plenum Press, 1995.
38. Gallagher TM, Buchmeiert MJ. Coronavirus spike protein in viral entry and pathogenesis. Virology 2001; 279: 371-4.
39. Brian DA, Hogue BG, Kienzle TE. The coronavirus hemagglutinin esterase glycoprotein. In: Stuart GS, ed. The Coronaviridae. New York: Plenum Press, 1995.
40. Yokomori K, Banner LR, Lai M. Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology 1991; 183: 647-57.
41. Zhang X, Kousoulas KG, Storz J. The hemagglutinin-esterase gene of human coronavirus strain OC43: phylogenetic relationships to bovine and murine coronaviruses and influenza C virus. Virology 1992; 186: 318-23.
42. Fisher F, Stegen CF, Masters PS, Samsonoff WA. Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly. J Virol 1998; 71: 996-1003.
43. Ng LFP, Wong M, Koh S, et al. Detection of severe acute respiratory syndrome coronavirus in blood of infected patients. J Clin Microbiol 2004; 42: 347-50.
44. Lai MM, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res 1997; 48: 1-100.
45. Delmas B, Gelfi J, L'Haridon, et al. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 1992; 357: 417-20.
46. Schultze B, Herrler G. Bovine coronavirus uses N-acetyl-9-O- acetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells. J Gen Virol 1992; 73: 901-6.
47. Williams RK, Jiang GS, Holmes KV. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci USA 1991; 88: 5533-6.
48. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzym 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450-4.
49. Hofmann H, Pyre K, van der Hoek L, Geier M, Berkhout B, Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA 2005; 102; 7988-93.
50. Almazan F, Gonzalez JM, Penzes Z, et al. Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 2000; 97: 5516-21.
51. Monto AS, Lim SK. The Tecumseh study of respiratory illness VI. Frequency and relationship between outbreaks of coronavirus infection. J Infect Dis 1974; 129: 271-6.
52. Vabret A, Mourez T, Gouarin S, Petitjean J, Freymuth F. An outbreak of coronavirus OC43 respiratory infection in Normandy, France. Clin Infect Dis 2003; 36: 985-9.
53. Moes E, Vijgen L, Keyaerts E, et al. A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis 2005; 5: 6.
54. Bastien N, Anderson K, Hart L, et al. Human coronavirus NL63 Infection in Canada. J Infect Dis 2005; 191: 503-6.
55. Arden KE, Nissen MD, Sloots TP, Mackay IM. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol 2005; 75: 455-62.
56. Ebihara T, Endo R, Ma X, Ishiguro N, Kikuta H. Detection of human coronavirus NL63 in young children with bronchiolitis. J Med Virol 2005; 75: 463-5.
57. Vabret A, Mourez T, Dina J, et al. Human coronavirus NL63, France. Emerg Infect Dis 2005; 11: 1225-9.
58. Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004; 303: 1666-9.
59. Desenclos JC, van der Werf S, Bonmarin I, et al. Introduction of SARS in France, March-April, 2003. Emerg Infect Dis 2004; 10: 195-200.
60. Syndrome respiratoire aigu sévère (SRAS). BEH 2003; 24-25.
61. Chan KH, Poon LL, Cheng VC, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 2004; 10: 294-9.
62. World Health Organization. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network, http://www.who. intCSR.sars/survival: May 04 2003.
63. Chim SS, Tsui SK, Chan KC, et al. CUHK Molecular SARS Research Group. Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong. Lancet 2003; 362: 1807-8.
64. Ijaz MK, Karim YG, Sattar SA, Johson-Lussenburg CM. Development of methods to study the survival of airborne viruses. J Virol Methods 1987; 18: 87-106.
65. Sizun J, Yu MW, Talbot PJ. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections. J Hosp Infect 2000; 46: 55-60.
66. Shen Z, Ning F, Zhou W, et al. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis 2004; 10: 256-60.
67. Myint SH. Human Coronaviruses: a brief review. Rev Med Virol 1994; 4: 35-46.
68. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801-9.
69. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986-94.
70. Nicholls JM, Poon LL, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361: 1773-8.
71. Sitbon M. Human-enteric-coronaviruslike particles (CVLP) with different epidemiological characteristics. J Med Virol 1985; 16: 67-76.
72. Zhang XM, Herbst W, Kousoulas KG, Storz J. Biological and genetic characterization of a hemagglutinating coronavirus isolated from a diarrhoeic child. J Med Virol 1994; 44: 152-61.
73. Chany C, Moscovici O, Lebon P, Rousset S. Association of coronavirus infection with neonatal necrotizing enterocolitis. Pediatrics 1982; 69: 209-14.
74. Salmi A, Ziola B, Hovi T, Reunanen M. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology 1982; 32: 292-5.
75. Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol 2000; 74: 8913-21.
76. Murray RS, Cai GY, Hoel K, Zhang JY, Soike KF, Cabirac GF. Coronavirus infects and causes demyelination in primate central nervous system. Virology 1992; 188: 274-84.
77. Vabret A, Mouthon F, Mourez T, Gouarin S, Petitjean J, Freymuth F. Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction. J Virol Methods 2001; 97: 59-66.
78. Stewart JN, Mounir S, Talbot PJ. Detection of coronaviruses by the polymerase chain reaction. In: Becker Y, Daraï G, eds. Diagnosis of human viruses by polymerase chain reaction technology. New York: Springer-Verlag, 1995.
79. Chan KH, Poon LL, Cheng VC, et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 2004; 10: 294-9.
80. Drosten C, Chiu LL, Panning M, et al. Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol 2004; 42: 2043-7.
81. Groneberg DA, Poutanen SM, Low DE, Lode H, Weite T, Zabel P. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis March 2005; 5: 147-55.
82. Herold J, Raabe T, Schelle-Prinz B, Sidell SG. Nucleotide sequence of the human coronavirus 229E RNA polymerase locus. Virology 1993; 195: 680-91.
83. Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003; 300: 1399-404.
84. Holmes KV, Enjuanes L. Virology: the SARS coronavirus, a post-genomic era. Science 2003; 300: 1377-8.